Michael Hogardt

Summary

Country: Germany

Publications

  1. ncbi Microevolution of Pseudomonas aeruginosa to a Chronic Pathogen of the Cystic Fibrosis Lung
    Michael Hogardt
    Department of Infectiology, Bavarian Health and Food Safety Authority, Veterinärstraße 2, 85764, Oberschleissheim, Germany
    Curr Top Microbiol Immunol 358:91-118. 2013
  2. ncbi Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
    Michael Hogardt
    Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
    Int J Med Microbiol 300:557-62. 2010

Collaborators

Detail Information

Publications2

  1. ncbi Microevolution of Pseudomonas aeruginosa to a Chronic Pathogen of the Cystic Fibrosis Lung
    Michael Hogardt
    Department of Infectiology, Bavarian Health and Food Safety Authority, Veterinärstraße 2, 85764, Oberschleissheim, Germany
    Curr Top Microbiol Immunol 358:91-118. 2013
    ..aeruginosa during CF lung infection will help to identify new targets for future anti-pseudomonal treatment strategies to prevent the selection of mutator isolates and the establishment of chronic CF lung infection...
  2. ncbi Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
    Michael Hogardt
    Bavarian Health and Food Safety Authority, Oberschleissheim, Germany
    Int J Med Microbiol 300:557-62. 2010
    ..aeruginosa variants, the antipseudomonal treatment, the prediction of the infectious disease state, and the development of efficient vaccines...